Ra Capital Management, L.P. Cogent Biosciences, Inc. Transaction History

Ra Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.24 $4.1 Million - $5.52 Million	416,666 Added 6.95%	6,416,147 $76 Million
Q4 2022 Feb 14, 2023	BUY	$10.65 - $14.84 $21.2 Million - $29.5 Million	1,986,028 Added 49.48%	5,999,481 $69.4 Million
Q3 2022 Nov 14, 2022	BUY	$9.39 - $16.99 $37.7 Million - $68.2 Million	4,013,453 New	4,013,453 $59.9 Million
Q1 2022 May 16, 2022	SELL	$5.31 - $8.7 $5.45 Million - $8.92 Million	-1,025,641 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $9.27 Million - $13.3 Million	1,025,641 New	1,025,641 $11.5 Million

170

113M

56.7K

40.4K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $585M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.